title: Opioid agonist/antagonist effect of naloxone in modulating rabbit jejunum contractility in vitro.
abstract: Opioid peptides are the most effective drugs in controlling pain; their action is elicited by binding to specific membrane receptors. The gastrointestinal tract represents, after the nervous system, the site in which the opioid receptors are expressed at high levels. The opioid agonist morphine has a significant inhibitory effect on intestinal motility, this action is blocked by naloxone an opioid antagonist mainly active at mu and kappa receptors. In this study the presence of mu opioid receptor on rabbit jejunum was investigated by western blot. The effects of beta-endorphin, the endogenous opioid peptide with the highest affinity to the mu opioid receptor and those of naloxone on spontaneous rabbit jejunum contractions were evaluated. Beta-endorphin (10(-6) M) showed a relaxant effect on jejunum contractility while naloxone showed a dual effect inducing an increase of spontaneous contractility at low concentrations (10(-6) M, 10(-7) M, 10(-8) M) and a decrease when high concentrations (10(-3) M, 10(-4) M, 10(-5) M) were utilized. The obtained results demonstrate that mu opioid receptor is expressed in rabbit jejunum and suggest that this receptor may be involved in mediating the effects of both opioid agonist and antagonist on jejunum contractions.
authors.affiliation: Dipartimento di Produzione Animale, Università degli Studi di Bari, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Cosola
authors.forename: M
authors.initials: M
authors.lastname: Albrizio
authors.forename: A C
authors.initials: AC
authors.lastname: Guaricci
authors.forename: M A
authors.initials: MA
authors.lastname: De Salvia
authors.forename: A
authors.initials: A
authors.lastname: Zarrilli
authors.forename: R L
authors.initials: RL
authors.lastname: Sciorsci
authors.forename: R
authors.initials: R
authors.lastname: Minoia
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D015153:Blotting, Western; D005769:Gastrointestinal Motility / Q000187:drug effects; D066298:In Vitro Techniques; D007583:Jejunum / Q000187:drug effects* / Q000378:metabolism; D009119:Muscle Contraction / Q000187:drug effects*; D009270:Naloxone / Q000494:pharmacology*; D009292:Narcotic Antagonists / Q000494:pharmacology*; D011817:Rabbits; D017450:Receptors, Opioid, mu / Q000187:drug effects / Q000378:metabolism*; D001615:beta-Endorphin / Q000494:pharmacology
chemical_list: D009292:Narcotic Antagonists; D017450:Receptors, Opioid, mu; D009270:Naloxone; D001615:beta-Endorphin